Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma

References

• Ozdoganoglu T, Songu M, Inancli HM. Quality of life in allergic rhinitis. Ther Adv Respir Dis. 2012;6(1):25–39. doi:10.1177/1753465811424425
   Web of Science ®Google Scholar
• Goksor E, Wennergren G, Vasileiadou S, et al. Increased prevalence of allergic rhinitis in young men in Western Sweden. Eur Res J. 2018;52 Supp:1.
   Web of Science ®Google Scholar
• Sur DK, Scandale S. Treatment of allergic rhinitis. Am Fam Physician. 2010;81(12):1440–1446.
   Web of Science ®Google Scholar
• Punekar YS, Sheikh A. Establishing the incidence and prevalence of clinician-diagnosed allergic conditions in children and adolescents using routinely collected data from general practices. Clin Exp Allergy. 2009;39(8):1209–1216. doi:10.1111/j.1365-2222.2009.03248.x
   Web of Science ®Google Scholar
• Calderon MA, Demoly P, Gerth van Wijk R, et al. EAACI: a European declaration on immunotherapy. Designing the future of allergen specific immunotherapy. Clin Transl Allergy. 2012;2(1):20. doi:10.1186/2045-7022-2-20
   PubMedGoogle Scholar
• Bousquet P-J, Chinn S, Janson C, et al. Geographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European community respiratory health survey I. Allergy. 2007;62(3):301–309. doi:10.1111/j.1398-9995.2006.01293.x
   PubMed Web of Science ®Google Scholar
• Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 health status questionnaire. J Allergy Clin Immunol. 1994;94(2 Pt 1):182–188. doi:10.1053/ai.1994.v94.a54939
   PubMed Web of Science ®Google Scholar
• Stuck BA, Czajkowski J, Hagner AE, et al. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol. 2004;113(4):663–668. doi:10.1016/j.jaci.2003.12.589
   PubMed Web of Science ®Google Scholar
• Bousquet J, Schunemann HJ, Samolinski B, et al. Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol. 2012;130(5):1049–1062. doi:10.1016/j.jaci.2012.07.053
   PubMed Web of Science ®Google Scholar
• Hyrkas-Palmu H, Ikaheimo TM, Laatikainen T, Jousilahti P, Jaakkola MS, Jaakkola JJK. Cold weather increases respiratory symptoms and functional disability especially among patients with asthma and allergic rhinitis. Sci Rep. 2018;8(1):10131. doi:10.1038/s41598-018-28466-y
   Web of Science ®Google Scholar
• Navarro A, Valero A, Julia B, Quirce S. Coexistence of asthma and allergic rhinitis in adult patients attending allergy clinics: ONEAIR study. J Investig Allergol Clin Immunol. 2008;18(4):233–238.
   Web of Science ®Google Scholar
• Marchetti P, Pesce G, Villani S, et al. Pollen concentrations and prevalence of asthma and allergic rhinitis in Italy: evidence from the GEIRD study. Sci Total Environ. 2017;584–585:1093–1099. doi:10.1016/j.scitotenv.2017.01.168
   Web of Science ®Google Scholar
• de Groot EP, Nijkamp A, Duiverman EJ, Brand PL. Allergic rhinitis is associated with poor asthma control in children with asthma. Thorax. 2012;67(7):582–587. doi:10.1136/thoraxjnl-2011-201168
   PubMed Web of Science ®Google Scholar
• Huang FL, Liao EC, Yu SJ. House dust mite allergy: its innate immune response and immunotherapy. Immunobiology. 2018;223(3):300–302. doi:10.1016/j.imbio.2017.10.035
   PubMed Web of Science ®Google Scholar
• Roberts G, Pfaar O, Akdis CA, et al. EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy. 2018;73(4):765–798. doi:10.1111/all.13317
   PubMed Web of Science ®Google Scholar
• Canonica GW, Cox L, Pawankar R, et al. Sublingual immunotherapy: world allergy organization position paper 2013 update. World Allergy Organ J. 2014;7(1):6. doi:10.1186/1939-4551-7-6
   PubMedGoogle Scholar
• Halken S, Larenas-Linnemann D, Roberts G, et al. EAACI guidelines on allergen immunotherapy: prevention of allergy. Pediatr Allergy Immunol. 2017;28(8):728–745. doi:10.1111/pai.12807
   PubMed Web of Science ®Google Scholar
• Manzotti G, Riario-Sforza GG, Dimatteo M, Scolari C, Makri E, Incorvaia C. Comparing the compliance to a short schedule of subcutaneous immunotherapy and to sublingual immunotherapy during three years of treatment. Eur Ann Allergy Clin Immunol. 2016;48(6):224–227.
   Google Scholar
• Senna G, Caminati M, Lockey RF. Allergen immunotherapy adherence in the real world: how bad is it and how can it be improved? Curr Treat Options Allergy. 2015;2:14. doi:10.1007/s40521-014-0037-6
   Google Scholar
• Incorvaia C, Mauro M, Leo G, Ridolo E. Adherence to sublingual immunotherapy. Curr Allergy Asthma Rep. 2016;16(2):12. doi:10.1007/s11882-015-0586-1
   PubMed Web of Science ®Google Scholar
• Senna G, Ridolo E, Calderon M, Lombardi C, Canonica GW, Passalacqua G. Evidence of adherence to allergen-specific immunotherapy. Curr Opin Allergy Clin Immunol. 2009;9(6):544–548. doi:10.1097/ACI.0b013e328332b8df
   PubMed Web of Science ®Google Scholar
• Bruggenjurgen B, Reinhold T. Cost-effectiveness of grass pollen subcutaneous immunotherapy (SCIT) compared to sublingual immunotherapy (SLIT) and symptomatic treatment in Austria, Spain, and Switzerland. J Med Econ. 2018;21(4):374–381. doi:10.1080/13696998.2017.1419959
   PubMed Web of Science ®Google Scholar
• Dhami S, Nurmatov U, Arasi S, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis. Allergy. 2017;72(11):1597–1631. doi:10.1111/all.13201
   PubMed Web of Science ®Google Scholar
• Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med. 1999;341(7):468–475. doi:10.1056/NEJM199908123410702
   PubMed Web of Science ®Google Scholar
• Valovirta E, Petersen TH, Piotrowska T, et al. Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy. J Allergy Clin Immunol. 2018;141(2):529–538 e513. doi:10.1016/j.jaci.2017.06.014
   PubMed Web of Science ®Google Scholar
• Eng PA, Borer-Reinhold M, Heijnen IA, Gnehm HP. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Allergy. 2006;61(2):198–201. doi:10.1111/j.1398-9995.2006.01011.x
   Web of Science ®Google Scholar
• Walker SM, Durham SR, Till SJ, et al. Immunotherapy for allergic rhinitis. Clin Exp Allergy. 2011;41(9):1177–1200. doi:10.1111/j.1365-2222.2011.03794.x
   PubMed Web of Science ®Google Scholar
• Penagos M, Eifan AO, Durham SR, Scadding GW. Duration of allergen immunotherapy for long-term efficacy in allergic rhinoconjunctivitis. Curr Treat Options Allergy. 2018;5(3):275–290. doi:10.1007/s40521-018-0176-2
   Google Scholar
• Breitkreuz J, Witte C, Zahn T. Saisonale Pollenallergien bei Kindern und Jugendlichen - Inanspruchnahme und Therapiepersistenz der spezifischen Immuntherapie. Monit Versorgungsforschung. 2019;2019(1):7.
   Google Scholar
• Egert-Schmidt AM, Kolbe JM, Mussler S, Thum-Oltmer S. Patients’ compliance with different administration routes for allergen immunotherapy in Germany. Patient Prefer Adherence. 2014;8:1475–1481. doi:10.2147/PPA.S70326
   PubMed Web of Science ®Google Scholar
• Tat T. Adherence to subcutaneous allergen immunotherapy in Southeast Turkey: a real-life study. Med Sci Monit. 2018;24:21. doi:10.12659/MSM.910860
   Web of Science ®Google Scholar
• Kiotseridis H, Arvidsson P, Backer V, Braendholt V, Tunsater A. Adherence and quality of life in adults and children during 3-years of SLIT treatment with grazax-a real life study. NPJ Prim Care Respir Med. 2018;28(1):4. doi:10.1038/s41533-018-0072-z
   PubMed Web of Science ®Google Scholar
• Lemberg ML, Berk T, Shah-Hosseini K, Kasche EM, Mosges R. Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center. Patient Prefer Adherence. 2017;11:63–70. doi:10.2147/PPA.S122948
   PubMed Web of Science ®Google Scholar
• Allam JP, Andreasen JN, Mette J, Serup-Hansen N, Wustenberg EG. Comparison of allergy immunotherapy medication persistence with a sublingual immunotherapy tablet versus subcutaneous immunotherapy in Germany. J Allergy Clin Immunol. 2018;141(5):1898–1901 e1895. doi:10.1016/j.jaci.2017.12.999
   PubMed Web of Science ®Google Scholar
• Wang T, Li Y, Wang F, Zhou C. Nonadherence to sublingual immunotherapy in allergic rhinitis: a real-life analysis. Int Forum Allergy Rhinol. 2017;7(4):389–392. doi:10.1002/alr.21909
   PubMed Web of Science ®Google Scholar
• Scadding GW, Calderon MA, Shamji MH, et al. Effect of 2 years of treatment with sublingual grass pollen immunotherapy on nasal response to allergen challenge at 3 years among patients with moderate to severe seasonal allergic rhinitis: the GRASS randomized clinical trial. JAMA. 2017;317(6):615–625. doi:10.1001/jama.2016.21040
   PubMed Web of Science ®Google Scholar
• Kronish IM, Ye S. Adherence to cardiovascular medications: lessons learned and future directions. Prog Cardiovasc Dis. 2013;55(6):590–600. doi:10.1016/j.pcad.2013.02.001
   PubMed Web of Science ®Google Scholar
• Baiardini I, Novakova S, Mihaicuta S, Oguzulgen IK, Canonica GW. Adherence to treatment in allergic respiratory diseases. Expert Rev Respir Med. 2018;13:1–10.
   Web of Science ®Google Scholar
• Sanchez J. Adherence to allergen immunotherapy improves when patients choose the route of administration: subcutaneous or sublingual. Allergol Immunopathol (Madr). 2015;43(5):436–441. doi:10.1016/j.aller.2014.04.011
   Web of Science ®Google Scholar
• Devillier P, Molimard M, Ansolabehere X, et al. Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: a retrospective database study in France. Allergy. 2019;74(7):1317–1326. doi:10.1111/all.13705
   PubMed Web of Science ®Google Scholar
• Devillier P, Wahn U, Zielen S, Heinrich J. Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis. Expert Rev Clin Immunol. 2017;13(12):1199–1206. doi:10.1080/1744666X.2017.1398082
   PubMed Web of Science ®Google Scholar
• Zielen S, Devillier P, Heinrich J, Richter H, Wahn U. Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: a retrospective, real-world database analysis. Allergy. 2018;73(1):165–177. doi:10.1111/all.13213
   PubMed Web of Science ®Google Scholar
• Röder E, Berger MY, Hop WCJ, Bernsen RMD, de Groot H, Gerth van Wijk R. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care. J Allergy Clin Immunol. 2007;119(4):892–898. doi:10.1016/j.jaci.2006.12.651
   PubMed Web of Science ®Google Scholar
• Schwanke T, Carragee E, Bremberg M, Reisacher WR. Quality-of-life outcomes in patients who underwent subcutaneous immunotherapy and sublingual immunotherapy in a real-world clinical setting. Am J Rhinol Allergy. 2017;31(5):310–316. doi:10.2500/ajra.2017.31.4465
   PubMed Web of Science ®Google Scholar
• Wallace D. Allergen immunotherapy: efficacy, persistence, consistency, and cost effectiveness. RUDN J Med. 2018;22(3):14. doi:10.22363/2313-0245-2018-22-3-288-301
   Google Scholar
• Vita D, Caminiti L, Ruggeri P, Pajno GB. Sublingual immunotherapy: adherence based on timing and monitoring control visits. Allergy. 2010;65(5):668–669. doi:10.1111/j.1398-9995.2009.02223.x
   Web of Science ®Google Scholar
• Camm AJ, Fox KAA. Strengths and weaknesses of ‘real-world’ studies involving non-vitamin K antagonist oral anticoagulants. Open Heart. 2018;5(1):e000788. doi:10.1136/openhrt-2018-000788
   PubMed Web of Science ®Google Scholar
• Berger ML, Mamdani M, Atkins D, Johnson ML. Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR good research practices for retrospective database analysis task force report–part I. Value Health. 2009;12(8):1044–1052. doi:10.1111/j.1524-4733.2009.00600.x
   PubMed Web of Science ®Google Scholar
• Himmel W, Hummers-Pradier E, Schümann H, Kochen MM. The predictive value of asthma medications to identify individuals with asthma–a study in German general practices. Br J Gen Pract. 2001;51(472):879.
   Web of Science ®Google Scholar